Literature DB >> 26991864

Delineation of a recognizable phenotype for the recurrent LCR22-C to D/E atypical 22q11.2 deletion.

Amaya Bengoa-Alonso1, Mercè Artigas-López1, María Moreno-Igoa1, Claudio Cattalli1, Blanca Hernández-Charro1, Maria Antonia Ramos-Arroyo1.   

Abstract

The 22q11.2 deletion syndrome is typically caused by haploinsufficiency of a 3 Mb region that extends from LCR22-A until LCR22-D, while the recurrent recombination between any of the LCR22-D to H causes the 22q11.2 distal deletion syndrome. Here, we describe three patients with a de novo atypical ∼1.4 Mb 22q11.2 deletion that involves LCR22-C to a region beyond D (LCR22-C to D/E), encompassing the distal portion of the typical deleted region and the proximal portion of the distal deletion. We also review six previous published patients with the same rearrangement and compare their features with those found in patients with overlapping deletions. Patients with LCR22-C to D/E deletion present a recognizable phenotype characterized by facial dysmorphic features, high frequency of cardiac defects, including conotruncal defects, prematurity, growth restriction, microcephaly, and mild developmental delay. Genotype-phenotype analysis of the patients indicates that CRKL and MAPK1 genes play an important role as causative factors for the main clinical features of the syndrome. In particular, CRKL gene seems to be involved in the occurrence of conotruncal cardiac anomalies, mainly tetralogy of Fallot.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11 deletion; CRKL; MAPK1; congenital heart defect; growth retardation; microcephaly; prematurity

Mesh:

Year:  2016        PMID: 26991864     DOI: 10.1002/ajmg.a.37614

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Immunodeficiency in a Patient with 22q11.2 Distal Deletion Syndrome and a p.Ala7dup Variant in the MAPK1 Gene.

Authors:  Ana I Sánchez; Mary A García-Acero; Angela Paredes; Rossi Quero; Rita I Ortega; Jorge A Rojas; Daniel Herrera; Miguel Parra; Karol Prieto; Juana Ángel; Luz-Stella Rodríguez; Juan C Prieto; Manuel Franco
Journal:  Mol Syndromol       Date:  2020-02-05

Review 2.  The 22q11.2 Microdeletion in Pediatric Patients with Cleft Lip, Palate, or Both and Congenital Heart Disease: A Systematic Review.

Authors:  Diana Cárdenas-Nieto; Maribel Forero-Castro; Clara Esteban-Pérez; Julio Martínez-Lozano; Ignacio Briceño-Balcázar
Journal:  J Pediatr Genet       Date:  2019-10-23

3.  Critical region within 22q11.2 linked to higher rate of autism spectrum disorder.

Authors:  Caitlin C Clements; Tara L Wenger; Alisa R Zoltowski; Jennifer R Bertollo; Judith S Miller; Ashley B de Marchena; Lauren M Mitteer; John C Carey; Benjamin E Yerys; Elaine H Zackai; Beverly S Emanuel; Donna M McDonald-McGinn; Robert T Schultz
Journal:  Mol Autism       Date:  2017-10-27       Impact factor: 6.476

4.  Prevalence of copy number variants (CNVs) and rhGH treatment efficacy in an Italian cohort of children born small for gestational age (SGA) with persistent short stature associated with a complex clinical phenotype.

Authors:  E Inzaghi; A Deodati; S Loddo; M Mucciolo; F Verdecchia; E Sallicandro; G Catino; M Cappa; A Novelli; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2021-07-13       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.